Literature DB >> 31715019

Human Tridimensional Neuronal Cultures for Phenotypic Drug Screening in Inherited Peripheral Neuropathies.

Renata Maciel1, Renata Correa1, Juliana Bosso Taniguchi1, Igor Prufer Araujo1, Mario A Saporta1.   

Abstract

Length-dependent axonal degeneration is the pathologic hallmark of several neurodegenerative disorders, including inherited peripheral neuropathies (Charcot-Marie-Tooth (CMT) disease). CMT is currently an untreatable disorder. This is partially due to lack of translational models suitable for drug discovery. In vitro models of CMT have been hindered by the 2D configuration of neuronal cultures, which limits visualization and orientation of axons. To overcome these limitations, we cultured induced pluripotent stem cell (iPSC)-derived spinal motor neurons as 3D spheroids, which grow axons in a centrifugal fashion when plated. Using these iPSC-derived spinal spheroids, we demonstrate neurofilament deposits in motor neuron axons of three patients with CMT2E, caused by mutations in the NEFL gene. This phenotype is partially reversed by two kinase inhibitors. In summary, we developed a human tridimensional in vitro system that models length-dependent axonopathies, recapitulates key pathophysiologic features of CMT2E, and should facilitate the identification of new therapeutic compounds for CMT.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31715019     DOI: 10.1002/cpt.1718

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  A Chemically Defined Common Medium for Culture of C2C12 Skeletal Muscle and Human Induced Pluripotent Stem Cell Derived Spinal Spheroids.

Authors:  Rachel R Besser; Annie C Bowles; Ahmad Alassaf; Daniel Carbonero; Renata Maciel; Mario Saporta; Ashutosh Agarwal
Journal:  Cell Mol Bioeng       Date:  2020-06-10       Impact factor: 2.321

2.  HDAC6 Inhibition Corrects Electrophysiological and Axonal Transport Deficits in a Human Stem Cell-Based Model of Charcot-Marie-Tooth Disease (Type 2D).

Authors:  Alec S T Smith; Jong Hyun Kim; Changho Chun; Ava Gharai; Hyo Won Moon; Eun Young Kim; Soo Hyun Nam; Nina Ha; Ju Young Song; Ki Wha Chung; Hyun Myung Doo; Jennifer Hesson; Julie Mathieu; Mark Bothwell; Byung-Ok Choi; Deok-Ho Kim
Journal:  Adv Biol (Weinh)       Date:  2021-12-26

3.  Optimized Protocol to Generate Spinal Motor Neuron Cells from Induced Pluripotent Stem Cells from Charcot Marie Tooth Patients.

Authors:  Pierre-Antoine Faye; Nicolas Vedrenne; Federica Miressi; Marion Rassat; Sergii Romanenko; Laurence Richard; Sylvie Bourthoumieu; Benoît Funalot; Franck Sturtz; Frederic Favreau; Anne-Sophie Lia
Journal:  Brain Sci       Date:  2020-06-27

4.  Allele-Specific Gene Editing Rescues Pathology in a Human Model of Charcot-Marie-Tooth Disease Type 2E.

Authors:  Carissa M Feliciano; Kenneth Wu; Hannah L Watry; Chiara B E Marley; Gokul N Ramadoss; Hana Y Ghanim; Angela Z Liu; Lyandysha V Zholudeva; Todd C McDevitt; Mario A Saporta; Bruce R Conklin; Luke M Judge
Journal:  Front Cell Dev Biol       Date:  2021-08-16

5.  Sequencing of neurofilament genes identified NEFH Ser787Arg as a novel risk variant of sporadic amyotrophic lateral sclerosis in Chinese subjects.

Authors:  Feng Lin; Wanhui Lin; Chaofeng Zhu; Jilan Lin; Junge Zhu; Xu-Ying Li; Zhanjun Wang; Chaodong Wang; Huapin Huang
Journal:  BMC Med Genomics       Date:  2021-09-11       Impact factor: 3.063

6.  Advantages of Adult Mouse Dorsal Root Ganglia Explant Culture in Investigating Myelination in an Inherited Neuropathic Mice Model.

Authors:  Yun Jeong Mo; Yu-Seon Kim; Minseok S Kim; Yun-Il Lee
Journal:  Methods Protoc       Date:  2022-07-22

Review 7.  Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.

Authors:  Marina Stavrou; Irene Sargiannidou; Elena Georgiou; Alexia Kagiava; Kleopas A Kleopa
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.